Propiedad y actividad de insiders de NRx Pharmaceuticals, Inc. (NRXP): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.35 |
| Capitalización | $58M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-01-27 | Casper Joseph Michael | A-Award | 100,000 | $239K |
| 2026-01-27 | Casper Joseph Michael | 100,000 | $239K | |
| 2025-04-09 | Javitt Jonathan C | A-Award | 125,000 | $216K |
| 2025-04-09 | McBride Dennis | A-Award | 25,000 | $43K |
| 2025-04-09 | Hurvitz Chaim | A-Award | 25,000 | $43K |
| 2025-04-09 | Flynn Patrick John | A-Award | 50,000 | $86K |
| 2025-08-18 | B Group, Inc. | |||
| 2025-02-07 | ABRAMS MICHAEL S | A-Award | 50,000 | $147K |
| 2024-12-17 | Javitt Jonathan C | P-Purchase | 40,000 | $47K |
| 2024-11-18 | ABRAMS MICHAEL S |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $449374 | $11079 | $6 | $1.9M | $27.6M | $20.1M | $4.6M | $1.4M | $7.8M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | $831000 | 0 | $7000 | $6000 | 0 | $161000 |
| Inventario | 0 | 0 | 0 | $214000 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $536376 | $30193 | $69489 | $2.9M | $32.7M | $25.8M | $6.9M | $3.3M | $8.9M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $633000 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.8M |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $925000 |
| Activos Totales | $69.6M | $70.8M | $32.1M | $2.9M | $32.7M | $25.8M | $7.3M | $3.7M | $13.0M |
| Cuentas por Pagar | $85671 | $551099 | 0 | $3.2M | $3.7M | $2.1M | $4.6M | $4.1M | $4.3M |
| Deuda a Corto | 0 | 0 | 0 | $249000 | $518000 | $7.7M | $9.2M | $1.6M | 0 |
| Pasivos Corrientes | $93171 | $567410 | $622441 | $46.2M | $11.9M | $15.6M | $19.0M | $21.9M | $28.6M |
| Deuda a Largo | 0 | $690000 | $2.0M | $548000 | 0 | $2.8M | 0 | $5.0M | 0 |
| Pasivos Totales | $93171 | $1.3M | $2.6M | $46.7M | $11.9M | $18.4M | $19.0M | $26.9M | $28.9M |
| Reservas | -$105033 | -$38932 | $369495 | -$90.2M | -$183.2M | -$223.0M | -$253.1M | -$278.3M | -$306.9M |
| Patrimonio Neto | $69.5M | $69.5M | $29.5M | -$43.8M | $20.8M | $7.4M | -$11.7M | -$23.2M | -$15.9M |
| Deuda Total | 0 | $690000 | $2.0M | $797000 | $518000 | $10.5M | $9.2M | $6.6M | $631000 |
| Deuda Neta | -$449374 | $678921 | $2.0M | -$1.1M | -$27.1M | -$9.5M | $4.6M | $5.1M | -$7.2M |
| Capital Circulante | $443205 | -$537217 | -$552952 | -$43.2M | $20.8M | $10.2M | -$12.2M | -$18.6M | -$19.7M |
Salud financiera
| Deuda / Patrimonio | -7.33 |
| Ratio corriente | 0.86 |
Rentabilidad
| Rentabilidad sobre capital | 168.68% |
| Rentabilidad sobre capital invertido | -1855.48% |
| Rentabilidad sobre activos | -68.74% |
| Margen bruto | 32.68% |
| Margen operativo | -588.24% |
| Margen neto | -691.81% |
Empresas relacionadas: COEP · CUE · EQ · HOWL · IOBT · IPSC · KPTI
Explorar sector: Healthcare · Biotechnology
Más secciones de NRXP: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones